NewAmsterdam Pharma Company NV
DUS:KH6
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
N
|
NewAmsterdam Pharma Company NV
DUS:KH6
|
NL |
|
N
|
Novartis AG
XHAM:NOT
|
CH |
|
Boeing Co
LSE:0BOE
|
US |
|
B
|
Boeing Co
XMUN:BCO
|
US |
|
Viscofan SA
F:VIS
|
ES |
|
V
|
Viscofan SA
XMUN:VIS
|
ES |
|
B
|
BlackRock Inc
XBER:BLQA
|
US |
|
B
|
Basf Se
SIX:BAS
|
DE |
|
N
|
NewAmsterdam Pharma Company NV
NASDAQ:NAMS
|
NL |
|
Arm Holdings PLC
LSE:0ADF
|
UK |
|
TotalEnergies SE
OTC:TTFNF
|
FR |
|
3
|
3D Systems Corp
BMV:DDD
|
US |
|
A
|
Akamai Technologies Inc
DUS:AK3
|
US |
|
U
|
UniCredit SpA
OTC:UNCFF
|
IT |
|
L
|
Las Vegas Sands Corp
BMV:LVS
|
US |
|
Nextera Energy Inc
NYSE:NEE
|
US |
|
A
|
Ageas SA
MIL:AGS
|
BE |
|
Koninklijke Philips NV
MIL:1PHIA
|
NL |
|
R
|
RWE AG
F:RWEA
|
DE |
Wall St Price Targets
KH6 Price Targets Summary
NewAmsterdam Pharma Company NV
According to Wall Street analysts, the average 1-year price target for KH6 is 45.79 EUR with a low forecast of 33.18 EUR and a high forecast of 54.46 EUR.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is KH6's stock price target?
Price Target
45.79
EUR
According to Wall Street analysts, the average 1-year price target for KH6 is 45.79 EUR with a low forecast of 33.18 EUR and a high forecast of 54.46 EUR.
What is the Revenue forecast for NewAmsterdam Pharma Company NV?
Projected CAGR
32%
The compound annual growth rate for Revenue over the next 11 years is 32%.